Introduction
The steadily increasing emergence of antibiotic resistant bacteria is a serious threat to global public health (World Health Organization, Boucher et al., 2013; Laxminarayan et al., 2013) . In pathogens isolated from clinical settings the majority of resistance mechanisms (by mutation or horizontal gene transfer) are genetically stable, where all cells in a population from a specific isolate show the same resistance phenotype. However, occasionally one observes isolates with heteroresistance, where different subpopulations within an isolate exhibit different susceptibilities to a particular antimicrobial agent (El-Halfawy and Valvano, 2015) . The gold standard for identifying heteroresistance is the Population Analysis Profile (PAP) method where cells (from a supposedly genetically homogenous population) are plated on different drug concentrations to determine the fraction of cells that can grow on each concentration. As suggested by El-Halfawy and Valvano (2013) a > eightfold difference in antibiotic concentration between the highest non-inhibitory concentration and the highest inhibitory concentration is needed to identify heteroresistance within a population of bacteria. The first report describing heteroresistance was published in 1947 for Haemophilus influenza (Alexander and Leidy, 1947) , but the term heteroresistance was not used until 1970 (Kayser et al., 1970) .
The increasing occurrences of multidrug resistant, extensively drug resistant and pandrug resistant Gramnegative bacteria (Magiorakos et al., 2012) have increased the use of colistin as a last resort drug (Gales et al., 2011) with a rapid increase in resistance (Meletis et al., 2011; Monaco et al., 2014; Bialvaei and Samadi, 2015) . Colistin (polymyxin E) and polymyxin B are polycationic antibiotics that act by replacing Ca 21 and Mg 21 in the lipopolysaccharide (LPS), causing loss of membrane integrity and cell death (Vaara, 2013) . Resistance towards polymyxins (Olaitan et al., 2014) in Gram-negative bacteria can be caused by: (i) alterations in the LPS that decrease its net negative charge (Peterson et al., 1987; Vaara et al., 1992; Nummila et al., 1995; Raetz et al., 2007) , (ii) loss of lipid A (Moffatt et al., 2010) , (iii) activation of efflux pumps (Bengoechea and Skurnik, 2000) and (iv) capsule shedding (Campos et al., 2004) . A majority of the identified colistin resistance mechanisms are encoded chromosomally, but the first plasmid encoded resistance gene, mcr-1, was reported in 2015 in Escherichia coli from human and food sources in China (Liu et al., 2015) . Alterations of the LPS, caused by mutations in the pmrAB (PmrA-response regulator, PmrB-histidine kinase sensor) two-component system (TCS) have been found in polymyxin resistant Gram-negative bacteria isolated from both clinical settings and laboratory selections (Fig. 1A and B) (Barrow and Kwon, 2009; Sun et al., 2009; Arroyo et al., 2011; Beceiro et al., 2011; Jayol et al., 2014) . These mutations cause increasing gene expression of pmrCAB, pmrE and arnBCADTEF genes (Arroyo et al., 2011; Moskowitz et al., 2012; Jayol et al., 2014) . The pmrCAB, pmrE and arnBCADTEF genes encode functions involved in synthesis and transfer of phosphoethanolamine (PEtN) and 4-amino-4-deoxy-L-arabinose (L-Ara4N) additions to lipid A, respectively, decreasing the net negative charge of the LPS in Gram-negative bacteria (Gunn et al., 1998 (Gunn et al., , 2000 Trent et al., 2001; Lee et al., 2004; Raetz et al., 2007) .
Another TCS involved in polymyxin resistance is PhoPQ. This system senses limiting concentrations of extra cytoplasmic Ca 21 and Mg 21 as well as the presence of cationic antimicrobial peptides in Salmonella enterica serovar Typhimurium (hereafter referred to as S. Typhimurium) and E. coli (Garc ıa V escovi et al., 1996; Kato et al., 1999; Bader et al., 2005; Prost and Miller; . In S. Typhimurium, the PhoPQ TCS indirectly activates the PmrAB TCS via PhoP-activated pmrD expression (Kox et al., 2000) . PmrD stabilizes and protects the phosphorylated form of PmrA from dephosphorylation by PmrB, leading to lipid A modifications (Kox et al., 2000; . PhoPQ TCS in E. coli also senses low concentrations of Mg 21 (Kato et al., 1999) but earlier studies showed that PmrA regulated genes are not activated (Winfield and Groisman; . However, in a recent study, PmrD together with PmrA was shown to be involved in L-Ara4N/PEtN modifications of lipid A, at low concentrations of Mg 21 in E. coli (Rubin et al., 2015) . The lipid A modifications were only to a small extent dependent on PhoPQ transcriptional activation, instead a second system or factor activating pmrD transcription under low Mg 21 concentrations was proposed.
Colistin or polymyxin B heteroresistance was first detected in clinical isolates of Acinetobacter baumanii in 2006 (Li et al., 2006) . Since then an increasing number of publications have reported colistin heteroresistance in clinical isolates of different Gram-negatives (Hawley (Schultz et al., 1998 (Schultz et al., ). et al., 2008 Yau et al., 2009; Meletis et al., 2011; Landman et al., 2013; Hermes et al., 2013; El-Halfawy and Valvano, 2013) but to our knowledge only two reports have presented possible genetic explanations for heteroresistance (Jayol et al., 2015; Lee et al., 2015) , both of which involve stable genetic mutations. In a recent report Band et al., highlighted the problem with an unstable colistin heteroresistant clinical Enterobacter cloacae isolate that was misclassified as susceptible and lead to treatment failure in a mouse model (Band et al., 2016) . The resistant subpopulation appeared genetically identical to the susceptible cell population but had increased transcription levels of the arn operon and pmrC causing the increase in resistance. Gene amplification as a cause of antibiotic resistance in bacteria was first discovered in plasmids (Sugino and Hirota, 1962) , and subsequently in chromosomal ß-lactamase genes of E. coli (Normark et al., 1977) and methicillin resistant Staphylococcus aureus (Matthews et al., 1987; Matthews and Stewart, 1988) . Resistance conferred by gene amplification is typically due to over production of target molecules, efflux pumps or antibiotic modifying enzymes (Sandegren and Andersson, 2009) . Gene amplifications are generally highly unstable: for example, in S. Typhimurium spontaneous tandem genetic duplications form and disappear at high rates in most regions of the genome and the frequency of cells with a duplication somewhere in the genome in a growing culture is estimated to be at least 10% (Anderson and Roth, 1981; Roth et al., 1996; Sun et al., 2012) . Since the characteristics of gene amplifications (high frequency in a population of cells and instability) are compatible with the properties of heteroresistance, it is conceivable that variability in gene copy number in a population might confer a heteroresistant phenotype. In accordance with this hypothesis, we demonstrate for S. Typhimurium that during selection for resistance at sub-MIC concentrations of colistin, resistance develops by gene amplification of a chromosomal region containing the pmrD gene. This amplification mechanism confers a typical heteroresistant phenotype where sub-populations have various levels of amplification of the pmrD gene, resulting in different levels of unstable colistin resistance.
Results
Resistance and heteroresistance in mutant strains of E. coli and S. Typhimurium obtained after selection at sub-MIC In this study we examined two species, E. coli (strain MG1655) and S. Typhimurium (strain LT2), with regard to mechanisms conferring colistin resistance during two different selective regimens, below MIC and above MIC. First, we determined if sub-MIC concentrations of colistin could select for colistin resistance in E. coli and S. Typhimurium. This was accomplished by performing serial passage experiments in Mueller-Hinton II (MH II) broth containing colistin at a concentration (0.015 mg/l) 50-fold below the MIC (0.75 mg/l) for 600 generations with 10 independent lineages each for E. coli and S. Typhimurium. At regular intervals, aliquots of culture were spread on agar plates containing different concentrations of colistin to determine the fraction of resistant mutants that had appeared and their level of resistance.
For S. Typhimurium, during the course of cycling the fraction of colistin resistant bacteria and the level of colistin resistance increased gradually with time in each lineage. At the end of the experiment (600 generations), 9 out of 10 lineages contained colistin resistant populations and eight of those linages had a dominant population with a high-level colistin resistance of 12 mg/l. Similarly, for E. coli at the end (600 generations) of the experiment, 6 out of 10 lineages showed a highly resistant population growing on 9 mg/l colistin.
Using Etests, the MIC levels were determined for three colistin resistant E. coli clones (DA27002, DA27003 and DA27004) obtained from the serial passage. The level of resistance and the presence of sub-populations were determined at two different inoculum sizes, by spreading with a cotton swab either 10 6 cells/ml, commonly used for Etests analysis, or 10 8 cells/ml. The levels of resistance varied between 1.5 and 3 mg/l for these three strains but none of them showed heteroresistance (Table 1) . For nine S. Typhimurium strains obtained from the serial passage (strains DA27006-DA27008 and DA27641-DA27646) the results were different. When 10 6 cells/ml were plated on Etests no resistant subpopulations were observed but if the inoculum size was increased to 10 8 cells/ml all S. typhiumurium strains showed heteroresistance ( Fig. 2A , Table 2 ). Thus, the main population in the Etest assay had the same MIC value as wild type S. Typhimurium (0.125 mg/l) but subpopulations of cells (observed as distinct colonies in the inhibition zone) with MIC values between 3 and 24 mg/l were observed for all nine S. Typhimurium mutants. To further examine the heterogeneity in resistance we performed a PAP (population analysis profiling) test where the bacterial population was subjected to a gradient of antibiotic concentrations on agar plates, and bacterial growth at each of these concentrations is quantified. In this analysis, the tested strains (DA27006-DA27008 and DA27641-DA27646) all showed clear heteroresistance with a 8-to 64-fold difference in colistin concentration between the highest non-inhibitory concentration and the highest inhibitory concentration (Supporting Information Fig. S1 ).
Resistance in mutant strains of E. coli and S. Typhimurium obtained after selection above MIC A set of 50 independent cultures of wild type E. coli was used to isolate colistin resistant E. coli on Mueller-Hinton II (MH II) plates containing 1.25 or 6.25 mg/l (10 or 50x MIC) of colistin. For S. Typhimurium, we used a set of colistin resistant mutants previously isolated in our laboratory at 1.25 or 6.25 mg/l (Sun et al., 2009) . The MICs of colistin for E. coli mutants selected above MIC (10 or 50x MIC) were 2-3 mg/l when 10 6 cells/ml were used as inoculum for Etest (strains DA34463-34467, Table 1 ). As a comparison, 27 examined S. Typhimurium colistin resistant mutants previously isolated at 10 or 50x MIC in our lab (Sun et al., 2009) , had MIC values in a similar range, 0.25-4.4 mg/l. None of the E. coli or S. Typhimurium mutants isolated showed any heteroresistance when plated with either 10 6 or 10 8 cells/ml in the Etest.
Mutations that confer colistin resistance in E. coli
Whole genome sequencing (WGS) showed that the three E. coli strains (DA27002 -DA27004) isolated at sub-MIC levels of colistin all contained mutations in the pmrB gene (Arg89Pro, Val88del and Leu110*) ( Table 1 , Fig. 1C ). After transferring the pmrB mutations into wild type background all reconstructed strains showed reduced susceptibility to colistin (1.5, 3 and 2 mg/l) in the same range as the original mutant strains (3, 2 and 1.5 mg/l), and well above wild type E. coli, 0.094 mg/l (Table 1) . Similarly, the eight E. coli mutants isolated at colistin concentrations (1.25 or 6.25 mg/l) above the MIC (0.094 mg/l) showed resistance levels of 3 mg/l and they all had mutations in either pmrA (Gly53Glu) or pmrB (Val88Glu, Arg93Pro) (Fig. 1C) . Thus, for E. coli, selection for colistin resistance at concentrations above MIC or below MIC only resulted in stable mutations in the pmrAB genes.
Mutations that confer colistin resistance in S. Typhimurium
For S. Typhimurium, in contrast to E. coli, different mutations conferring colistin resistance were found when selection occurred below or above the MIC. Thus, as demonstrated by an earlier study of ours isolation of colistin resistant mutants above MIC (at 1.25 and 6.25 mg/l) resulted, similarly to E. coli, in selection of genetically stable pmrAB mutants with a level of resistance in the range of 0.5 to 4.4 mg/l (Sun et al., 2009) . However, when the selection was performed at sub-MIC levels (0.015 mg/l, 50-fold below the MIC), a completely different mutation spectrum was observed. Under those selection conditions, none of the S. Typhimurium isolates had mutations in pmrAB but instead they had mutations in other genes ( Table 2) . One of the most common mutational types observed in 7 out of 9 strains (DA27006, 27007 and DA27641, DA27643-DA27646), was chromosomal amplification. Amplifications were initially detected by the 2-to eightfold increased coverage in the whole genome sequence data, and subsequently PCR and DNA sequencing was used to identify the amplification endpoints of DA27006, DA27007 and 270046 ( Fig. 2B and C, Supporting Information Fig. S2 and Table 2 ). The amplification join points of three tested isolates showed no detectable homology that could be involved in the initial recombination event (Supporting Information Fig. S2 ). The amplifications had different sizes (49 to 301 kb) and end points but all had a common region of the chromosome amplified that contained the pmrD gene and the arnBCAD-TEF operon ( Fig. 2B and C), known to be involved in colistin resistance (Groisman et al., 1997; Gunn et al., 1998) . The appearance of colistin resistance in four analyzed linages (lineages A, C, D, H) in the sub-MIC serial passage experiment coincide with the first time point where chromosomal amplifications containing the pmrD gene and arnBCADTEF operon were detected. In lineages A, D and H colistin resistance as well as chromosomal amplifications were present in the cell population after 200 generations (but not at 100 generations) and for the fourth lineage (C) colistin resistance and chromosomal amplification was present after 400 generations (but not at 300 generations). These findings imply that colistin resistance in these strains was associated with amplification of the pmrD and arnBCADTEF genes.
The level of chromosomal amplification (copy number) of the pmrD gene determines the level of colistin resistance To demonstrate that the increased level of resistance was due to chromosomal amplifications, we used qPCR to measure gene copy numbers of pmrD and nuoA (present in the men-nuo amplified region, Fig. 2 ) in cells grown with or without colistin at 1 mg/l. A colistin resistant mutant with amplification and an arcA mutation (strain DA27641) originally isolated in the sub-MIC serial passage experiment was used as an ancestral strain (Table  2) . After serial passage for 40 generations in absence of colistin the cell population had an average copy number C. The chromosomal genes present in the amplified region common between the seven colistin resistant S. Typhimurium strains. Genes indicated in green and red are the arnBCADTEF genes and the pmrD gene, respectively. The pmr, men-nuo and the pmr-men-nuo regions describe the three duplications that were constructed and analyzed.
of 2.5 of pmrD and only 34% of the cell population grew on colistin plates (3.75 mg/l, 5x MIC). When the same strain was serially passaged with colistin present (1 mg/l) for 20 generations the pmrD gene copy number increased to 6 and 100% of the cell population grew on colistin plates (3.75 mg/l). After transferring the colistin-passaged strain back to an additional 20 generations of growth without colistin the pmrD gene copy number subsequently decreased to 3 and only 33% of the cell population grew on colistin plates (3.75 mg/l). Thus, as expected, in the presence of colistin there was selection for increased pmrD copy number and colistin resistance, whereas in the absence of colistin the unstable tandem amplifications segregated to a lower copy number yielding lower resistance. These experiments demonstrate that copy number and level of resistance are associated.
To define which gene(s) conferred resistance when amplified, we constructed three different types of amplifications of pre-determined regions (strains DA32962, pmr, 11.3 kb; DA33039, pmr-men-nuo, 47 kb; and DA33040, e. All heteroresistant isolates had a main cell population with a MIC between 0.125 and 0.380. In addition they all had subpopulations of cells growing at higher colistin concentrations as indicated by colonies growing above the MIC of the main cell population. All heteroresistant isolates isolated at sub-MIC was also confirmed as heteroresistant by the PAP method.
men-nuo, 35.5 kb; Table 2 ) with a bla-cassette at the duplication join point (Supporting Information Fig. S3, Fig.  2C ). The level of penicillin resistance is proportional to the bla copy number, and by growing the cells in the presence of different penicillin concentrations we could isolate cells with different copy numbers of the chromosomal regions and determine the occurrence of colistin heteroresistance/resistance (Fig. 3) . Colistin heteroresistance/resistance was detected in the strain with an amplified pmr region, containing pmrD and arnBCADTEF (strain DA32962) and in the strain with an amplified pmr-men-nuo region (strain DA33039). In contrast, amplification of the men-nuo region did not lead to colistin heteroresistance/resistance, showing that resistance is associated with amplification of the pmr region (containing the pmrD gene and the arnBCADTEF operon). The level of amplification also influenced resistance such that when the pmr region (pmrD, arnBCADTEF) was present in less than approximately four copies, no colistin resistance was seen on Etest with either 10 6 cells/ml or 10 8 cells/ml of plated cells. With an intermediate copy number of approximately 6 copies, heteroresistance was detected on the Etest with 10 6 cells/ml. When the copy number was increased to approximately 10 or more copies, all cells showed high-level resistance (no heteroresistance) when 10 6 cells/ml were plated for the Etests.
To determine the fitness costs of carrying the amplified regions pmr and pmr-men-nuo, we selected for high-level amplification by growing strains with either a pmr or pmr-men-nuo duplication (Fig. 2C) on cephalotin overnight. The cells were then shifted to a medium without drug and growth rates of cultures with amplifications, and control cultures with the original duplications or single copy were determined. Parts of the cultures were used for qPCR analysis of DNA copy number after growth. Our results show that cells with copy numbers of 9 and 5 of the pmr and pmr-men-nuo regions, respectively, were indistinguishable in growth rate from cells with 1 copy (Supporting Information Fig. S5 ). Thus, these amplifications confer a fitness cost of less than 2% (sensitivity of growth rate assays).
Over-expression of pmrD is both required and sufficient to confer colistin resistance Based on which genes were included in the amplified region, we hypothesized that it was amplification and an increase of the copy number of the pmrD gene that conferred resistance. To examine this idea, we performed two different tests. If an increase in PmrD levels is necessary and sufficient to confer colistin resistance, it is expected that deletion of the pmrD gene in the constructed amplified strains should prevent appearance of resistance and, conversely, that overexpression of pmrD without the amplification should confer resistance. First, we constructed a strain where the pmrD gene and concentrations. Gene copy number of pmrD and nuoA was determined with qPCR. The pmr and the pmr-men-nuo regions describe the duplications constructed with the insertion of a bla-cassette (Supporting Information Fig. S3 ) at the duplication join point. The two reference genes used in the analysis were cysG and hcaT. The values represented the mean (6SD) of three biological replicates. The dashed line indicates 1 gene copy on the chromosome. B. Correlation between increased concentrations of colistin and selection for increased copy number of pmrD. The numbers and shapes of the distributions are approximate since the copy numbers determined are averages for the whole population (i.e., the exact copy number distribution in the different populations is unknown).
arnBCADTEF operon were amplified but the pmrD gene was inactivated (strain DA33538). In this strain, colistin resistance/heteroresistance was abolished and no growth of colonies on colistin containing MH II plates (2x MIC and higher) was observed. Also, transcription of the arnB, arnT, pmrA, pmrC and pmrE genes involved in colistin resistance was abolished when the pmrD gene was non functional in wild type S. Typhimurium and in the two strains with the pmr region (strain DA32962) and the pmr-men-nuo region (strain DA33039) amplified (Fig. 4 and Supporting Information Fig. S3 ). These findings demonstrate that amplification of the pmrD gene is required for the increased resistance. Second, we cloned the pmrD gene on a plasmid under control of an arabinose-inducible promoter and showed that in the presence of 0.1% arabinose, MIC of colistin increased to 8 mg/l (0.094 mg/l for empty plasmid) as compared to 0.032 mg/l in the non-induced state. This result demonstrated that over-expression of pmrD alone is sufficient to confer resistance. This finding is also supported by previous experiments showing that cloning of pmrD into medium and high copy number plasmids causes polymyxin B and E (colistin) resistance in S. Typhimurium (Roland et al., 1994; Kox et al., 2000) . To examine if this is also the case for E. coli, we cloned the pmrD gene from E. coli into a plasmid carrying an arabinoseinducible promoter and transferred it into E. coli strain MG1655. In contrast to S. Typhimurium, induction of the pmrD gene in E. coli caused no increase in colistin resistance, indicating that these two species differ in their dependence on PmrD for resistance.
Clinical evidence for gene amplification as a cause of heteroresistance
To try to obtain evidence for pmrD gene amplification in clinical isolates we screened several E. coli, S. Typhimurium, Acinetobacter baumanii and Klebsiella pneumoniae isolates for colistin heteroresistance. Even though none of them showed colistin heteroresistance, they did show unstable heteroresistance towards several other antibiotics and preliminary data indicate that for a substantial fraction of the isolates the heteroresistance is associated with tandem gene amplification (K. Hjort, H. Nicoloff and D. I. Andersson, unpublished data). As an example, one of the clinical isolates of S. Typhimurium showed tetracycline heteroresistance in an Etest and during selection in presence of tetracycline the population became fully resistant and after growth in absence of tetracycline heteroresistance reappeared (Supporting Information Fig. S4A) . A WGS analysis demonstrated that a genomic region containing the tetG and tetA genes was amplified (about 30 times increased sequence coverage) when the isolate was grown under tetracycline selection that decreased (about 20-fold) after serial passage for 40 generations in medium without tetracycline. The heteroresistant phenotype was also confirmed with a PAP analysis (Supporting Information  Fig. S4B ).
Role of the arcA gene mutations
The most common mutation type (8 out of 9 mutants) found in the S. Typhimurium colistin resistant strains (DA27006-DA27008, DA27641-27645) isolated during serial passage at sub-MIC of colistin was mutations in the arcA gene (Table 2 ). These mutations were the first mutations to appear in the cell population in the serial passage experiment. However, none of the three reconstructed arcA mutations (Leu50Gln, Val9Leu or Thr111Pro) conferred any detectable increase in colistin resistance when transferred to a wild type S. Typhimurium background, suggesting that they are not selected as resistance mutations. In contrast, in a competition experiment the arcA mutants (mutations Leu50Gln and Val9Leu) showed an increased fitness of 1-1.7% (SD 0.3%) in media with colistin (sub-MIC level, 0.015 mg/l) and an increased fitness of 1.7% (SD 0.3%) in media without colistin as compared to wild type S. Typhimurium. This finding suggests that the arcA mutations are media adaptation mutations that are selected in the sub-MIC serial passage experiments because they increase the growth rate in the used medium, rather than increasing resistance to colistin.
Discussion
We analyzed mutations that conferred resistance to colistin in E. coli and S. Typhimurium for resistant mutants selected either at concentrations far below the MIC (1/ 50 of MIC) or well above the MIC (10 and 50x MIC). At high concentrations of colistin, we found the classical, genetically stable pmrAB mutations in both E. coli (this study) and S. Typhimurium (Sun et al., 2009 ). In contrast, at low concentrations of colistin the mutational spectra were different between the two species such that the E. coli mutants carried pmrAB mutations while S. Typhimurium mutants contained unstable amplifications of the pmrD gene (Figs. 2 and 5 , Tables 1 and 2 ). This latter type of mutation also provides an explanation for how heteroresistance to colistin might be generated (see below). The reasons for why E. coli and S. Typhimurium differ in which mutants are selected at sub-MIC concentrations of colistin, could be linked to their partially different regulations of PmrD expression (Kox et al., 2000; Kato et al., 2003; Winfield and Groisman, 2004; Rubin et al., 2015) . Common for both E. coli and S. Typhimurium is that PmrD is involved in the regulation of the genes responsible for modifications in lipid A (L-Ara4N and PEtN) that lead to colistin resistance. However, pmrD expression in S. Typhimurium is PhoPQ dependent (Winfield and Groisman, 2004) and in E. coli, expression of pmrD is only partially dependent of PhoPQ (Rubin et al., 2015) . In their article, Rubin et al. speculate that there are additional unknown factors or systems that could be involved in activation of pmrD expression in E. coli. This notion is supported by our finding that pmrD over-expression in E. coli does not, in contrast to S. Typhimurium, cause an increased colistin resistance.
With regard to the pmrAB mutations, they were found both during selections below and above MIC for E. coli, but for S. Typhimurium only with selections above MIC (Fig. 5, Sun et al., 2009 ). Mutations in the pmrAB genes have previously been detected in E. coli from poultry and swine (Quesada et al., 2015) and in vitro selected colistin resistant mutants of S. Typhimurium and E. coli (Sun et al., 2009; Lee et al., 2015) and the types of mutations found in E. coli from this study are similar to those previously isolated (Froelich et al., 2006; Sun et al., 2009) . The E. coli pmrA mutation, located in the phosphate receiver domain (Gly53Glu) has been isolated earlier in S. Typhimurium responsible for colistin resistance (Fig. 1C) (Sun et al., 2009) . In E. coli a different amino acid substitution (Gly53Val) for the same amino acid position was shown to constitutively overexpress the promoters of pmrH (arnB) and pmrC in a Typhimurium and E. coli after colistin treatment above and below the minimal inhibitory concentration (MIC). Mutations in pmrA and pmrB caused colistin resistance after selection at high colistin concentrations (10 or 50x above MIC) in E. coli and S. Typhimurium and in E. coli after selection at low colistin concentration (1/50 of MIC). Over-expression of pmrC and arnBCADTEFH due to mutations in pmrAB introduces modifications in lipid A that cause colistin resistance. At low colistin concentration (1/50 of MIC) in S. Typhimurium amplifications of pmrD conferred increased resistance. The pmrD gene copy number correlates with resistance such that less than approximately four pmrD gene copies generates a colistin susceptible cell population, above approximatly 10 gene copies leads to colistin resistance and at an intermediate pmrD gene copy number heteroresistance appears. These numbers are approximate since the copy numbers determined are averages for the whole population (i.e., the exact copy number distribution in the population is unknown).
polymyxin B resistant mutant (Froelich et al., 2006) . All of the E. coli colistin resistance mutations in PmrB that appeared at either sub-inhibitory or high concentrations of colistin are either located just before the start or in the HAMP domain (Fig. 1C, Table 1 ). HAMP domains (Histidine kinases, Adenylyl cyclases, Methyl-binding proteins and phosphatases domain) are often present in TCS and are proposed to transduce signals from extracytoplasmic sensing domains to cytoplasmic domains (Matamouros et al., 2015) . PmrB mutations in the HAMP domain have previously been shown to cause constitutive activation of the PmrB protein leading to colistin resistance (Olaitan et al., 2014) .
The main finding in this study was that during sub-MIC selection with S. Typhimurium amplifications of the pmrD gene were selected and that they caused colistin heteroresistance (Fig. 5) . All the duplications found in our experiment were unstable and could be further amplified by growth in the presence of colistin, and conversely in the absence of colistin the amplifications segregated to lower copy numbers. The heteroresistance observed coincided with increased copy number of pmrD (Fig. 3) , and this correlation was seen for both the duplications found in the serial passage experiments and those that were genetically constructed. Furthermore, by either deleting or over-expressing pmrD we showed that an increase in PmrD levels is both necessary and sufficient to confer colistin resistance. How increased dosage of PmrD protein (via the increase in pmrD gene copy number) confers colistin resistance is explained by previous work. The regulatory protein, PmrD is involved in the regulation of the two-component system PmrAB in S. Typhimurium where it connects the two TCS PhoPQ and PmrAB (Kox et al., 2000; Kato and Groisman, 2004; Winfield and Groisman, 2004; Chen and Groisman, 2013) . In S. Typhimurium PhoPQ senses CAMPs, low pH and Mg 21 that leads to phosphorylation of the transcriptional regulator PhoP which up-regulates PmrD expression. The PmrD protein then binds and stabilizes the phosphorylated form of PmrA, inhibiting dephosphorylation (Kato and Groisman, 2004) . Phosphorylated PmrA up-regulates the transcription of pmrCAB and arnBCADTEFT operons encoding functions that introduce modifications of the lipid A that increase resistance to colistin (Fig. 1A and B ) (Gunn et al., 1998; Raetz et al., 2007) . Even though heteroresistance in clinical isolates was reported as early as 1947, few mechanistic explanations for heteroresistance have been reported (El-Halfawy and Valvano, 2015) . The prevalence of heteroresistance in clinical isolates has increased and in some instances the heteroresistance for A. baumanii and K. pneumoniae is more prevalent than stable colistin resistance (Li et al., 2006; Poudyal et al., 2008; Rodriguez et al., 2009; Yau et al., 2009; Meletis et al., 2011) . Recently Jayol et al. published an explanation for heteroresistance in colistin resistant K. pneumonia, where the heteroresistant clone consisted of a mixture of genetically different cells with alterations in the PhoP protein. In that case the heteroresistance was genetically stable and the two different isolated cells remained susceptible and resistant, respectively, when re-tested separately (Jayol et al., 2015) . Another recent report presented unstable colistin heteroresistant isolates of P. aeruginosa, A. baumanii and E. coli with pmrB mutations that reverted to susceptibility by gaining additional stable mutations in the same gene or in phoPQ (Lee et al., 2015) . Thus, both these reported cases explain heteroresistance as a result of mixes of genetically stable variants. In contrast, in the report of Band et al no genetic differences were reported for the unstable colistin heteroresistance (Band et al., 2016) .
Our findings provide a new mechanism for heteroresistance where unstable tandem gene amplification generates population heterogeneity. We propose that such alteration in gene copy number is a major cause for the unstable heteroresistance observed in many clinical isolates. This idea is supported by the general characteristics of tandem gene duplications/amplifications in bacteria. Thus, the frequency of spontaneous duplications in growing cultures of, for example, S. Typhimurium and E. coli is very high and the frequency of cells that have a duplication of any specific gene is in the range of 10 25 to 10 22 (Anderson and Roth, 1981; Roth et al., 1996; Pettersson et al., 2008; Andersson and Hughes, 2009; Sun et al., 2012) . In a population, this provides a large standing genetic variation available for selection to act on and as a result selection for gene amplification is very common when the selective problem (e.g., presence of colistin) can be resolved by an increase in dosage of a limiting protein (e.g., PmrD). Furthermore, both the rates of formation and loss of duplications are high (the steady-state frequency is largely determined by the ratio of the formation and loss rates and any potential effects of the amplification on fitness, Reams et al., 2010) . Importantly, in the absence of selection amplifications are highly unstable (loss rates might be as high as 15% per cell per generation due to RecA-dependent homologous recombination) (Pettersson et al., 2008; Reams et al., 2010; Roth et al., 1996) . Thus, the high steady-state frequency and intrinsic instability of tandem gene duplications/amplifications are compatible with the characteristics of unstable heteroresistance where a major part of the population lacks a duplication/amplification of the relevant resistance gene (resulting in susceptibility) and a small fraction of the population carries an intrinsically unstable duplication/amplification of the resistance gene (resulting in unstable resistance).
During selection in the presence of drug, the fraction of resistant cells will increase and conversely in the absence of drug the fraction of resistant cells decreases because of the instability and potential fitness costs associated with the amplification. This reasoning also explains why heteroresistance is easier to detect on Etests when more cells are plated since this increases the absolute number of cells with a duplication/amplification of the resistance-conferring gene present on the plate. Finally, it is notable that for both S. Typhimurium and E. coli concentrations of colistin as low as 1/50 of the MIC are sufficiently high to select for highly resistant mutants from a wild type population. This finding concurs with previous work demonstrating that sub-MIC concentrations of several other antibiotics can enrich and select for resistant bacteria at concentrations several hundred-fold below the MIC of susceptible bacteria (Gullberg et al., 2011; Liu et al., 2011; Gullberg et al., 2014) . Thus, overall these findings imply that very low drug concentrations (MIC) often are sufficiently high to ensure that resistance genes/mutations are maintained and selected in bacterial populations (Baquero and Coque, 2014) .
Experimental procedures

Strains and growth conditions
Bacterial strains used in this study were wild type or derivatives of Escherichia coli MG1655 and Salmonella enterica serovar Typhimurium LT2 (referred to as Salmonella Typhimurium) (Tables 1 and 2 and Supporting Information Table  S1 ). Strains were grown in Mueller-Hinton II (MH II, Becton Dickinson AB) media or on MH II agar plates at 378C.
MIC measurements
The minimum inhibitory concentration (MIC) was determined using Etests (bioM erieux, Marcy I 0 Etoile, France) on MH II agar plates. As inoculum a solution of 10 6 or 10 8 cells/ml in 0.9% sodium chloride was applied with a cotton swab onto the MH II plates followed by application of an Etest strip. The plates were incubated for 16-20 h at 378C. The MIC of colistin for wild type E. coli was 0.094 mg/l and for wild type S. Typhimurium 0.125 mg/l.
Population analysis profile
Over night cultures of colistin heteroresistant S. Typhimurium strains DA27006-DA27008 and DA27641-27646 (Table  2 ) grown in MH II medium were used for the population analysis profile. Five ml of the over night culture (containing approx. 3 x 10 9 cells/ml) or 10 time serial dilutions down to 10 26 was transferred by pipetting on to MH II plates and MH II plates containing different concentrations of colistin (0.125, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 mg/ml). The plates were incubated over night and the colonies were counted and colony number was plotted in a graph to determine if the PAP fulfilled the criteria for heteroresistance as suggested by El-Halfawy and Valvano (2015) . Hence, there should be at least a 8-fold difference in antibiotic concentration between the highest non-inhibitory concentration and the highest inhibitory concentration.
Isolation of resistant E. coli and S. Typhimurium at colistin concentrations below MIC Ten independent lineages, each of susceptible wild type E. coli MG1655 (strain DA5438) and S. Typhimurium LT2 (strain DA6192) were grown at a sub-MIC concentration of 1/50 of the MIC (0.015 mg/l) of colistin (MIC for wild type bacteria was 0.75 mg/l) in MH II media. The cell cultures were serially passaged every 24 h for 600 generations (10 generations of growth per 24 h) by transferring 1 ml of culture to 1 ml new medium (1000-fold dilution). The emergence of colistin resistance was monitored every 100 generations by plating 10 5 cells onto MH II plates containing increasing concentrations of colistin (1.5-12 mg/l). Colistin resistant colonies were isolated after 600 generations and re-streaked on colistin plates containing the same colistin concentration as the mutant was initially isolated on. Four E. coli and nine S. typimurium clones were grown on MH II plates with colistin (same concentration as the isolate was isolated on) and subsequently grown in MH II media over night before DNA was extracted for WGS analysis. For comparison eight lineages of wild type E. coli and S. Typhimurium were serially passaged as described above without addition of colistin for 500 generations.
Isolation of resistant E. Coli at colistin concentrations above MIC
Fifty independent cultures of wild type E. coli MG1655 (strain DA5438) were grown over night and then 10 7 cells from each culture were plated on MH II plates with 1.25 or 6.25 mg/l of colistin. Five independent mutants with resistance towards colistin were re-streaked at the same colistin concentration as the initial isolation to confirm their resistance. Two (strains DA34465 and DA34467) of these mutants were WGS. For the other three mutants the pmrA and pmrB genes were locally sequenced. All five strains were Etested to determine the level of increased colistin resistance. For S. Typhimurium a set of 44 colistin resistant mutants previously isolated in the same way as above in our laboratory (at high colistin concentrations of 1.25 or 6.25 mg/l) were used (Sun et al., 2009) .
Whole genome sequencing
Three milliliters of over night cultures grown in MH II without colistin were used for the preparation of chromosomal DNA using the Genomic-tip 100/G kit (Qiagen) combined with the genomic DNA buffer kit (Qiagen) according to manufacturer's recommendation. The genomic DNA was sequenced by BGI (Hongkong, China) using Illumina High Seq 2000 and 500 bp pair-end libraries with an average of 50x coverage of the chromosome. Mutations and DNA amplifications were identified by re-assembling DNA sequences using the CLC Genomic Workbench software (Qiagen) to our in-house reference genomes of E. coli MG1655 and S. Typhimurium LT2.
PCR and local sequencing
Genes of interest were PCR amplified with primers (Supporting Information Table S2 ) binding upstream and downstream of the genes using DreamTaq DNA polymerase and sequenced. PCR and sequencing was also used to detect and validate amplification break points in serial passage experiment at sub-MIC concentrations of colistin with S. Typhimurium and experimentally designed stable amplifications in S. Typhimurium. Primers were designed to generate a PCR product covering the unique break points generated by the amplifications (Supporting Information  Table S2 ). All PCR products were purified and sequenced by Eurofins MWG operon.
Re-constructions of mutations in a wild type genetic background
Selected mutations detected in S. Typhimurium LT2 and E. coli MG1655 from the sub-MIC experiment were transferred into wild type genetic background, strains DA6192 and DA5438 respectively, using linear transformation and Lambda-Red recombineering (Datsenko and Wanner, 2000; Yu et al., 2000) . In brief, a chloramphenicol marker was PCR amplified from the strain DA18397 with primers (Supporting Information Table S2 ) containing extensions of 40 bp homologous to the insertion point, 7-10 kbp (S. Typhimurium) or 11-13 kbp (E. coli) away from the mutation of interest. For S. Typhimurium the mutations were moved with P22 transduction and for E. coli with P1 transduction into wild type genetic background (S. Typhimurium, DA6192 and E. coli, DA5438) and the chloramphenicol cassette was flipped with the Flp recombinase. All reconstructed strains were confirmed with local sequencing. For each constructed mutant a corresponding strain was constructed as control only carrying an FRT-scar.
Determination of the order in which mutations arise in the evolved bacterial cultures
The order of appearance of the mutations in the S. Typhimurium lineages evolving in the sub-MIC serial passages experiment was determined by local sequencing of each mutated gene (Table 2, Supporting Information Table S2 ) every 100 generation. The junction points of the amplified regions were PCR amplified and sequenced for the S. Typhimurium serial passage experiment every 100 generations.
Construction of chromosomal duplications with pre-determined endpoints
Three different constructs were made that had three different chromosomal regions duplicated. The genomic regions represented the entire common sequence of the amplifications from 7 colistin resistant S. Typhimurium strains (Table  2 , DA27006, DA27007, DA27641, DA27643-DA27646) or two parts of it (Fig. 2) . The chromosomal regions amplified were: (i) pmr, 11.3 kb in size starting upstream of yfaX to upstream of pmrD (strain DA32962), (ii) pmr-men-nuo, 47 kb in size starting upstream of yfaX to upstream of yfbU (strain DA33039) and (iii) men-nuo 35.5 kb in size starting upstream of pmrD to upstream of yfbU (strain DA33040).
To amplify and regulate the level of amplification an ampicillin resistance marker (bla-cassette) was amplified from the plasmid pEL3A15 (Supporting Information Fig. S3 ). The primers contained a 40 bp homology to the insertion point of the bla-cassette in the S. Typhimurium genome and were inserted with Lambda-Red recombineering (Supporting Information Table S2 ). The sequence homology of the primers to the chromosome made it possible to amplify parts (pmr, pmr-men-nuo and men-nuo regions) of the chromosome through recombination during the insertion of the blacassette. As the level of resistance to ampicillin is directly proportional to the copy number of the bla gene, cells with different levels of amplification of the constructed duplications could be analyzed for gene copy number (qPCR on pmrD and nuoA) and transcription levels (RT-qPCR on pmrA, pmrC, pmrD, pmrE, arnB and arnT).
Construction of a strain with a non-functional pmrD gene
We constructed a strain with a non-functional pmrD gene (strain DA33607) by inserting a chloramphenicol resistance cassette into the pmrD gene (pmrD 1-91::FRT-cat-FRT) in wild type S. Typhimurium (strain DA6192) using LambdaRed recombineering (Supporting Information Table S2 ). This non-functional pmrD strain was subsequently used for construction (as described above) of three strains (DA33538, DA33539 and DA33540) that contained different amplified chromosomal regions (pmr, pmr-men-nuo and men-nuo) and with a bla-cassette at the duplication join point.
Determination of mRNA levels and gene copy number
Quantitative PCR (qPCR) was used to analyze mRNA levels of pmrA, pmrC, pmrD, pmrE, arnB and arnT as well as the gene copy numbers of pmrD and nuoA. The two genes hcaT and cysG outside the amplified region were used as internal controls (Brandis et al., 2016; Kn€ oppel et al., 2016) . For the analysis of mRNA levels total RNA from exponentially growing cultures (OD 600 5 0.15-0.3) of triplicate biological samples was extracted with the RNeasy Mini Kit (Qiagen). The RNA samples were DNase treated using the turbo DNA-free kit (ThermoFisher Scientific) followed by generation of cDNA with the High capacity cDNA Reverse Transcription kit (ThermoFisher scientific). For the analysis The qPCR mix consisted of 5 ml of perfeCTa SYBR Green FastMix, 0.5 ml each of forward and reverse primers (Supporting Information Table S2 ), 4 ml of one of the following dilutions 1:100, 1:1000 or 1:10 000 in water of overnight cell culture for the gene copy analysis or cDNA for the transcriptional level analysis. The qPCR was analyzed with the Eco Real-Time PCR system (Illumina, San Diego, CA, USA) using the PerFeCTa SYBR green fastmix (Quanta biosciences). Three biological replicates were analyzed with all three dilutions of cell culture giving a total of nine samples. The gene copy number and transcriptional levels were calculated by the following formula: gene copy number or transcriptional level 5 2 CT(control) 2 CT(target) .
Construction of an arabinose inducible plasmid overexpressing PmrD
The pmrD gene together with its ribosomal binding site was amplified from wild type S. Typhimurium LT2 (strain DA6192) and E. coli MG1655 (strain DA5438) with primers containing XbaI and HindIII restriction sites (Supporting Information Table S2 ). The pmrD gene and the pBAD30 vector (Guzman et al., 1995) were digested with XbaI and HindIII and the pmrD insert was subsequently ligated behind the arabinose-inducible promoter in the vector. The constructs were transformed into the same strain where the pmrD gene originated from ie. wild type S. Typhimurium (strain DA6192) or wild type E. coli (DA5438) (Supporting Information Table S1 ). PmrD was overexpressed with the addition of 0.1% arabinose into Minimal M9 agar plates with 0.2% glycerol for MIC measurements with Etests. As a control the MIC was determined with an un-induced pmrD gene and S. Typhimurium or E. coli containing the pBAD30 vector without insert.
Growth rate measurements and copy number determination of the constructed amplified pmr and pmr-men-nuo regions of S. Typhimurium
The growth rates (OD 600 ) of six biological replicates of wild type S. Typhimurium (strain DA6192) and two S. Typhimurium strains with amplified genomic regions (pmr, strain DA32962 or pmr-men-nuo, strain DA33039) under the control of cephalotine were measured in a Bioscreen C reader (Labsystem) every 4 min. Six clones for each sample were inoculated in 1 ml of MH II medium supplemented with 4 mg/l of cephalotin to select for amplification of the pmr and pmr-men-nuo regions for 10 generations. All cell cultures were subsequently diluted 1:1000 in MH II medium supplemented with 4 mg/l of cephalotin to keep the selection during the initial growth in the Bioscreen. Before the cells with amplifications reached late log phase (2-4 generations) the measurements were stopped and all cell cultures were diluted 1:100 in pre-warmed non-selective medium (MH II) and the growth rate was measured in the Bioscreen, once again the measurements were interrupted before the cells reached late log phase (2-4 generations).
OD 600 values between 0.02 and 0.08, where the growth of the bacteria was observed to be exponential, were used to calculate maximum growth rate. The relative growth rate was calculated by dividing the growth rate of each strain with the wild type strain of S. Typhimurium (DA6192). Four samples from the second growth measurement (after 1:100 dilution) out of the initial six biological replicates were used to determine the copy number of pmrD and nuoA with qPCR to correlate copy number to fitness cost.
Competition experiments
Competition experiments between wild type S. Typhimurium and mutants containing an arcA mutation Val9Leu (originally found in strain DA27007) or Leu50Gln (originally found in strain DA27006) were performed. For detection of fluorescent populations in the MACSQuant (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), S. Typhimurium containing either mTagBFP2_opt-kan (strain DA27187) or SYFP2_opt-kan (strain DA27189) fluorescent tags were used. Lambda-Red recombineering (Supporting Information  Table S2 ) and transduction with P22 phage was used to introduce the arcA mutations Leu50Gln (strain DA27006) and Val9Leu (strain DA27007) into the bfp (strain DA27187) and yfp (strain DA27189) containing strains. To determine the fitness cost of the two fluorescent markers (yfp and bfp), two strains carrying the bfp and yfp, respectively, were competed against each other.
The competition experiments were performed using four biological replicates and a dye swap, making a total of eight measurements for each sample. The inoculum size was approximately 10 6 cells, with a ratio of bfp and yfp cells of 1:1 in 1 ml of MH II media supplemented with 0.015 mg/l or without colistin. The cells were grown for a total of 30 generations (10 generations per 24 h) and the cell cultures was diluted 1:1000 every 24 h. The ratio of cells with the mutated arcA versus wild type arcA was calculated from 10 5 cells at every serial passage (10 generations) in MACSQuant.
